Primary Site >> Colorectal Cancer

Gene >> LRBA

Journal: Radiother Oncol. 2010 May;95(2):203-8.
Title: Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer.
Author: Janssen, Marco H M|Ollers, Michel C|van Stiphout, Ruud G P M|Riedl, Robert G|van den Bogaard, Jorgen|Buijsen, Jeroen|Lambin, Philippe|Lammering, Guido
PMID: 20176406
Journal: Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):152-63.
Title: Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
Author: Maffione, Anna Margherita|Lopci, Egesta|Bluemel, Christina|Giammarile, Francesco|Herrmann, Ken|Rubello, Domenico
PMID: 25319712
Journal: Ann Oncol. 2017 Jun 1;28(suppl_3). pii: 3916894.
Title: LBA-007FOLFOX/Bevacizumab +/- Irinotecan in advanced colorectal cancer (AIO) "CHARTA": Final results and multivariate prognostic factor analysis.
Author: Schmoll, Hans-Joachim|Garlipp, Benjamin|Junghanss, Christian|Leithauser, Malte|Vogel, Arndt|Schaefers, Michael|Kaiser, Ulrich|Hoeffkes, Heinz-Gert|Florschutz, Axel|Russel, Jorn|Kanzler, Stephan|Edelmann, Thomas|Forstbauer, Helmut|Gohler, Thomas|Hannig, Ca
PMID: 30052789
Journal: Ann Oncol. 2017 Jun 1;28(suppl_3). pii: 3916898.
Title: LBA-010Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance).
Author: Sinicrope Frank, A|Shi, Qian|Hermitte, Fabienne|Heying, Erica|Benson Al, B|Gill, Sharlene|Goldberg Richard, M|Kahlenberg, Morton|Nair, Suresh|Shields, Anthony|Sargent, Dan|Galon, Jerome|Alberts Steven, R
PMID: 30052792
Journal: Oncol Lett. 2018 Jun;15(6):9413-9419.
Title: Screening for susceptibility genes in hereditary non-polyposis colorectal cancer.
Author: Yu, Li|Yin, Bo|Qu, Kaiying|Li, Jingjing|Jin, Qiao|Liu, Ling|Liu, Chunlan|Zhu, Yuxing|Wang, Qi|Peng, Xiaowei|Zhou, Jianda|Cao, Peiguo|Cao, Ke
PMID: 29844832